Gennova sees uptick in its Omicron-specific Covid booster
Pune-based biotech firm Gennova Biopharmaceuticals has witnessed a demand uptick for its Omicron-specific Covid-19 vaccine, with the recent surge in Coronavirus cases. Gemcovac-OM, which was approved in June, is the country’s first mRNA-based vaccine which may work well against JN.1, the variant in circulation at present, a company official told TOI. The vaccine is priced … Read more